These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10365742)

  • 1. Clotting activation after transjugular intrahepatic portosystemic stent shunt.
    Basili S; Merli M; Ferro D; Lionetti R; Rossi E; Riggio O; Valeriano V; Capocaccia L; Violi F
    Thromb Haemost; 1999 May; 81(5):711-4. PubMed ID: 10365742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ongoing prothrombotic state in the portal circulation of cirrhotic patients.
    Violi F; Ferro D; Basili S; Lionetti R; Rossi E; Merli M; Riggio O; Bezzi M; Capocaccia L
    Thromb Haemost; 1997 Jan; 77(1):44-7. PubMed ID: 9031447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.
    Gulberg V; Deibert P; Ochs A; Rossle M; Gerbes AL
    Hepatogastroenterology; 1999; 46(26):1126-30. PubMed ID: 10370679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.
    Sauer P; Hansmann J; Richter GM; Stremmel W; Stiehl A
    Endoscopy; 2002 Sep; 34(9):690-7. PubMed ID: 12195325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
    Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
    J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin effect on thromboelastography after transjugular intrahepatic portosystemic shunt procedure.
    Thalheimer U; Triantos C; Samonakis D; Patch D; Burroughs AK
    Scand J Gastroenterol; 2009; 44(12):1463-70. PubMed ID: 19958060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation.
    Itkin M; Trerotola SO; Stavropoulos SW; Patel A; Mondschein JI; Soulen MC; Tuite CM; Shlansky-Goldberg RD; Faust TW; Reddy KR; Solomon JA; Clark TW
    J Vasc Interv Radiol; 2006 Jan; 17(1):55-62. PubMed ID: 16415133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.
    Masson S; Mardini HA; Rose JD; Record CO
    QJM; 2008 Jun; 101(6):493-501. PubMed ID: 18440957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.
    Kramer L; Bauer E; Gendo A; Funk G; Madl C; Pidlich J; Gangl A
    Am J Gastroenterol; 2002 Jan; 97(1):162-6. PubMed ID: 11808942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathological investigation of the transjugular intrahepatic portocaval shunt (TIPS)].
    Ziarkiewicz-Wróblewska B; Wróblewski T; Górnicka B; Michałowicz B; Rowiński O; Bogdańska M; Krawczyk M
    Przegl Lek; 2001; 58(11):992-4. PubMed ID: 11987842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIPS implantation raises leptin levels in patients with liver cirrhosis.
    Nolte W; Wirtz M; Rossbach C; Leonhardt U; Buchwald AB; Scholz KH; Ramadori G
    Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):435-42. PubMed ID: 14614651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients.
    Vidal V; Joly L; Perreault P; Bouchard L; Lafortune M; Pomier-Layrargues G
    Cardiovasc Intervent Radiol; 2006; 29(2):216-9. PubMed ID: 16284702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis.
    Van Ha TG; Hodge J; Funaki B; Lorenz J; Rosenblum J; Straus C; Leef J
    Cardiovasc Intervent Radiol; 2006; 29(5):785-90. PubMed ID: 16850140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Sugiura procedure for conditioning of the blood stream through TIPSS in cirrhotic patient. Initial experience.
    Danis J; Gruenwald M; Krieg J
    Hepatogastroenterology; 2000; 47(35):1205-7. PubMed ID: 11100312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
    Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
    Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
    Chalasani N; Gorski JC; Patel NH; Hall SD; Galinsky RE
    Hepatology; 2001 Dec; 34(6):1103-8. PubMed ID: 11731998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.